← Stock Trading Canary · All insider profiles
INSIDER PROFILE · ES
CERTIMAB CONTROL, S.L.
Persona Estrechamente Vinculada
Profile key: es|certimab control, s.l.
Purchase history
- Companies traded
- 1
- Purchases · 12M
- 36
- Purchases · 24M
- 37
- Average purchase
- €75,907
- Gross purchase value
- €2,808,546
- Last purchase
- 2026-06-19
- Completed 20D events
- 22.0
- Outcome status
- PASS
Latest company: ALANTRA PARTNERS, S.A.
Companies: ALANTRA PARTNERS, S.A.
Post-purchase outcomes
Benchmark-relative outcomes are available against IBEX 35.
- Excess return = stock return − IBEX 35 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 22Established | 100.0% (22/22) | 31.8% (7/22) | -1.8% | -1.4% | -5.6% |
| 20D | 22Established | 100.0% (22/22) | 13.6% (3/22) | -6.6% | -5.3% | -9.1% |
| 60D | 22Established | 100.0% (22/22) | 0.0% (0/22) | -11.6% | -11.2% | -16.2% |
| 120D | 1Small sample | 100.0% (1/1) | 0.0% (0/1) | -3.8% | -3.8% | -3.8% |
Research patterns
- First purchase in 12M
- 1/22
- Large purchase ≥ €100k
- 8/22
- Cluster buying · 15D
- 0/22
- Buying the dip · ≥20% below prior 52W high
- 0/22
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.